Research projects conducted by the German Breast Group
The German Breast Group conducts research into breast cancer, developing and implementing its own study concepts.
With the help of additional scientific research projects, we strive to gain further insights into this disease.
Research News
-
05.11.2018 October 2018: Long-term survival analysis of GeparSixto trial
The survival analysis of patients with triple-negative and HER2-positive early breast cancer enrolled in the neoadjuvant GeparSixto (GBG 66) phase II trial have been published in the Annals of Oncology.
-
15.10.2018 GBG Research at ESMO
Data of several GBG trials and translational research projects will be presented at the upcoming ESMO 2018 Congress, which will take place from 19 to 23 October in Munich, Germany.
-
27.09.2018 Paper of the month: models for pCR
A statistical research study that aimed to develop an empirical model for predicting the magnitude of the treatment effects on survival endpoints based on the treatment effects on pathological complete response (pCR) has been published in the Contemporary Clinical Trials.
-
31.08.2018 Paper of the month: Endocrine Therapy in HEGR2 neg mBC
A review that summarized the available data on endocrine therapy for premenopausal women with HER2-negative hormone receptor-positive metastatic breast cancer (MBC) has been published in the Oncologist.
-
28.08.2018 GBG 79 BrainMet (BMBC): erste Daten publiziert
Die erste Analyse der BMBC-Registerstudie zur Versorgung von Patientinnen mit Hirnmetastasen wurde im European Journal of Cancer veröffentlicht.
Paper of the month
Every month, we present an interesting paper.
-
18.11.2022 Desiree: dose escalation of everolimus published
We are proud to inform you that our article A multicentre, randomised, double-blind, phase II study to evaluate the tolerability of an induction dose escalation of everolimus in patients with metastatic breast cancer (DESIREE; GBG 86) is now available online.